LONDON — The Saudi Food and Drug Authority (SFDA) signed a memorandum of understanding (MoU) with the UK's Veterinary Medicines Directorate (VMD) to strengthen cooperation in the regulation of veterinary medicines and products. The agreement was signed by SFDA Chief Executive Officer Dr. Hisham bin Saad Al-Jadhey and VMD Chief Executive Abigail Seager on the sidelines of a meeting of the International Coalition of Medicines Regulatory Authorities (ICMRA) working group on the development of medicines for small populations and rare diseases, held in London. The MoU aims to facilitate the exchange of regulatory and supervisory information and expertise to improve regulatory practices and enhance safety. It also covers cooperation and the exchange of expertise on the regulation and availability of veterinary medicines, evaluation requirements, regulatory practices and laboratory testing. The agreement includes oversight of manufacturers and veterinary products before and after marketing, as well as drawing on the expertise of specialists from both sides and implementing training programs to strengthen technical and regulatory capabilities. The MoU also builds on the SFDA's efforts to strengthen its international partnerships, advance the regulatory framework, enhance the safety of veterinary medicines and help protect animal health and livestock in Saudi Arabia, including horses, falcons and camels, which hold a special place in the Kingdom's national heritage and